Motazedi Abbas MD - DC District of Columbia, Washington 20017

Motazedi Abbas MD entered the industry of Endocrinologists in 1992 and has grown to employ 1 to 4 people, generating an annual revenue of $500.000 to $999.999. The NAICS classifies this business under the code 6211110, which describes it as a Endocrinologists. For further clarification, the SIC classifies this business under the code 8011 and described it as a Endocrinologists. The business provides service to the B2C market.

To acquire more information, please contact Abbas Motazedi by calling (202) 269-0381 during business hours. You can also write to the business’ Single Location at 1160 Varnum St Ne # 111, Washington, District of Columbia DC 20017. You can also visit the company’s website at centerofdiabetes.com. View this business’ social media profiles on Twitter or on Facebbok .

Company: Motazedi Abbas MD
Representative: Abbas Motazedi
Place of Business: 1160 Varnum St Ne # 111, Washington, DC 20017
Contact Number: (202) 269-0381
Website: centerofdiabetes.com
Type of Service: Endocrinologists
SIC Number: 8011
NAICS Number: 6211110
Locality: Single Location
Market Type: B2C (Business to Consumer)
Began: 1992
Income/Year: $500.000 to $999.999
Laborers: 1 to 4
Share This Company:

Motazedi Abbas MD is a company operating from District of Columbia, District of Columbia providing professional Endocrinologists and relevant B2C variables. It was founded in 1992 and registered with the SIC code 8011 as Endocrinologists, and with the NAICS code 6211110 as Endocrinologists.

With a current employee count of 1 to 4, Motazedi Abbas MD has gone to report making $500.000 to $999.999 per annum on its journey towards growth. This company invites you to contact its representative Abbas Motazedi at (202) 269-0381 for related queries, or to locate its Single Location using the coordinates 38.942923,-76.992208.

The Single Location can also be found at the street address 1160 Varnum St Ne # 111 in Washington, District of Columbia 20017 and can be engaged online through the company website at centerofdiabetes.com, the company Twitter , and Facebook page .